These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1266887)

  • 1. Serum viscosity and hyperviscosity syndrome in IGG multiple myeloma - the relationship of Sia test and to concentration of M component.
    Pruzanski W; Russell ML
    Am J Med Sci; 1976; 271(2):145-50. PubMed ID: 1266887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG myeloma, Sia test, and serum hyperviscosity.
    Rubies-Prat J; Gallart MT; Frison JC; Caralps A; Schwartz S; Bacardi R
    Acta Haematol; 1974; 52(2):107-11. PubMed ID: 4214602
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperviscosity syndrome in dysproteinemias.
    Buxbaum J
    Am J Med Sci; 1972 Aug; 264(2):123-6. PubMed ID: 4631633
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between serum viscosity and intravascular IgA polymer concentration in IgA myeloma.
    Chandy KG; Stockley RA; Leonard RC; Crockson RA; Burnett D; MacLennan IC
    Clin Exp Immunol; 1981 Dec; 46(3):653-61. PubMed ID: 7337982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of hyperviscosity in monoclonal gammopathies.
    Crawford J; Cox EB; Cohen HJ
    Am J Med; 1985 Jul; 79(1):13-22. PubMed ID: 4014299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperviscosity syndrome with IgA myeloma.
    Dine ME; Guay AT; Snyder LM
    Am J Med Sci; 1972 Aug; 264(2):111-5. PubMed ID: 4653114
    [No Abstract]   [Full Text] [Related]  

  • 7. The hyperviscosity syndrome. I. In IgG myeloma. The role of protein concentration and molecular shape.
    MacKenzie MR; Fudenberg HH; O'Reilly RA
    J Clin Invest; 1970 Jan; 49(1):15-20. PubMed ID: 5409803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of IgA myeloma proteins isolated rom sera of patients with the hyperviscosity syndrome.
    Mestecky J; Hammack WJ; Kulhavy R; Wright GP; Tomana M
    J Lab Clin Med; 1977 May; 89(5):919-27. PubMed ID: 404374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of IgG lambda myeloma associated with hyperviscosity syndrome. A speculative mechanism of hyperviscosity syndrome with relative low serum viscosity (author's transl)].
    Katsuki A; Shimazaki C; Osamura K; Nakanishi S; Kayawake S; Sasaki T; Murano K; Nakata T; Nishio A; Hosoda M; Haruyama H; Matsushima K; Ijichi H; Isemura T
    Rinsho Ketsueki; 1979 Jun; 20(6):658-66. PubMed ID: 112269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperviscosity syndrome in plasma cell dyscrasias].
    Somer T
    Duodecim; 1977; 93(9):586-603. PubMed ID: 406132
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunochemical and physical studies of the Sia test.
    Keystone E; Pruzanski W
    Am J Med Sci; 1976; 271(2):151-7. PubMed ID: 817599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperviscosity syndrome in multiple myeloma. A reversible, concentration-dependent aggregation of the myeloma protein.
    Lindsley H; Teller D; Noonan B; Peterson M; Mannik M
    Am J Med; 1973 May; 54(5):682-8. PubMed ID: 4701949
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperviscosity syndrome in paraproteinemia. Managed by plasma exchange; monitored by serum tests.
    Beck JR; Quinn BM; Meier FA; Rawnsley HM
    Transfusion; 1982; 22(1):51-3. PubMed ID: 6801828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [D-myeloma (observation of 8 cases)].
    Mokeeva RA; Verevkin IN; Piasik MV; Grigorian GD; Rybakova ME
    Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):41-5. PubMed ID: 6795618
    [No Abstract]   [Full Text] [Related]  

  • 15. IgG heavy-chain subclass typing of myeloma paraproteins by isoelectric focusing immunoblot analysis.
    Fasullo FJ; Fritsche HA; Liu FJ; Hamilton RG
    Clin Chem; 1989 Mar; 35(3):364-8. PubMed ID: 2493340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudohypoproteinemia and multiple myeloma.
    Avashia JH; Walsh TD; Valenzuela R; Fernando Quevedo J; Clough J
    Cleve Clin J Med; 1990 May; 57(3):298-300. PubMed ID: 2357786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation phenomenon in an IgG multiple myeloma resulting in the hyperviscosity syndrome.
    Benninger GW; Kreps SI
    Am J Med; 1971 Aug; 51(2):287-93. PubMed ID: 5095532
    [No Abstract]   [Full Text] [Related]  

  • 18. Technical aspects of the detection and characterization of immunoglobulin dyscrasis.
    Conway BP
    Health Lab Sci; 1972 Jul; 9(3):185-96. PubMed ID: 4625660
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple myeloma in a patient with sickel cell anemia. Interacting effects on blood viscosity.
    Anderson IS; Yeung KY; Hillman D; Lessin LS
    Am J Med; 1975 Oct; 59(4):568-74. PubMed ID: 810022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperviscosity syndrome as the initial manifestation of IgG myeloma].
    Luna G; Lite M; Abad JA
    Rev Clin Esp; 1982 Aug 15-31; 166(3-4):181-2. PubMed ID: 6815728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.